Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Strain Analysis as a Right Ventricle Contractility Marker

30 oktober 2019 uppdaterad av: Hospices Civils de Lyon
The analysis of the systolic function (contractility) of the right ventricle (RV) is fundamental and central in many pathologies in intensive care unit. It can guide physicians in choosing therapeutics. The conventional ultrasound markers of RV function evaluation currently used are influenced by RV loading conditions, impairing their capacity to approximate a true contractility analysis. Myocardial strain imaging is a recent echographic technique that allows, among other things, to evaluate RV systolic function. It is a reproducible index with early variations which, if it proved to be independent pre-load, would help to better appreciate the RV contractility.

Studieöversikt

Status

Avslutad

Betingelser

Intervention / Behandling

Studietyp

Interventionell

Inskrivning (Faktisk)

16

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Lyon, Frankrike, 69004
        • Hôpital de La Croix Rousse
      • Lyon, Frankrike, 69007
        • Hôpital Saint Joseph Saint Luc

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Male or female ≥ 18 years
  • Patients with renal failure treated with intermittent hemodialysis
  • Patients who received an information and did not opposed to participate in the study, or, if unconscious patient at the time of inclusion: a person of trust as defined in Article L. 1111-6 of the Public Health Code, failing that, the family or, failing that, a person maintaining stable link, having received information and not opposed to participate in the study.

Exclusion Criteria:

  • Patients with heart disease (valvular, ischemic, rhythmic)
  • Patients with ejection fraction of left ventricular altered <45%
  • Chronic dialysis patients
  • Patients referred in Articles L. 1121-5, L.1121-6, L.1121-7, L.1121-8 of the Public Health Code:

    • Pregnant women, parturients or nursing mothers
    • Persons deprived of their liberty by a judicial or administrative decision, persons subject to psychiatric care, persons admitted to a health or social institution for purposes other than research
    • Minor Patients
    • Major persons who are subject to a legal protection measure or are unable to express their consent
  • Patients not willing to participate in the study
  • Patients not affiliated to a social security

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Diagnostisk
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Övrig: ultrasound measurements
ultrasound measurements of myocardial deformation of free wall right ventricle during a sharp decline of right ventricle preload induced during a session of Intermittent hemodialysis.
ultrasound measurements of myocardial deformation of free wall right ventricle at 4 time points during a session of intermittent hemodialysis : before the intermittent hemodialysis connection, just after starting hemodialysis, after 1 hour of hemodialysis and 5 minutes before restitution

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Evaluation of the change in the Longitudinal strain of the free wall right ventricle
Tidsram: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Evaluation of the change in S' right ventricle wave
Tidsram: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
Evaluation of the change in tricuspid annular plane systolic excursion (TAPSE)
Tidsram: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
Evaluation of the change in visual left ventricular ejection fraction (LVEF)
Tidsram: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
Evaluation of the change in mitral E wave
Tidsram: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
Evaluation of the change in mitral A wave
Tidsram: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
Evaluation of the change in wave E ' at the lateral mitral ring
Tidsram: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
Evaluation of the change in systolic fraction of pulmonary venous flow
Tidsram: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
inter individual variability of Longitudinal strain of the free wall right ventricle
Tidsram: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
Each measurement will be performed by two blind operators
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
intra individual variability of Longitudinal strain of the free wall right ventricle
Tidsram: at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
Each measurement will be performed by two blind operators
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Zoé Schmitt, Hôpital de la Croix-Rousse

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

25 november 2016

Primärt slutförande (Faktisk)

31 december 2017

Avslutad studie (Faktisk)

31 december 2017

Studieregistreringsdatum

Först inskickad

10 mars 2017

Först inskickad som uppfyllde QC-kriterierna

20 mars 2017

Första postat (Faktisk)

24 mars 2017

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

31 oktober 2019

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

30 oktober 2019

Senast verifierad

1 oktober 2019

Mer information

Termer relaterade till denna studie

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera